Why Lineage Cell Therapeutics Inc (AMEX: LCTX) Stock Shouldn’t Be Ignored In 2024
In today’s recent session, 3.38 million shares of the Lineage Cell Therapeutics Inc (AMEX:LCTX) have been traded, and its beta is 1.27. Most recently the
In today’s recent session, 3.38 million shares of the Lineage Cell Therapeutics Inc (AMEX:LCTX) have been traded, and its beta is 1.27. Most recently the
In last trading session, Lineage Cell Therapeutics Inc (AMEX:LCTX) saw 0.58 million shares changing hands with its beta currently measuring 1.27. Company’s recent per share
During the last session, Lineage Cell Therapeutics Inc (AMEX:LCTX)’s traded shares were 0.43 million, with the beta value of the company hitting 1.28. At the
In last trading session, Lineage Cell Therapeutics Inc (AMEX:LCTX) saw 1.17 million shares changing hands with its beta currently measuring 1.27. Company’s recent per share
During the last session, Lineage Cell Therapeutics Inc (AMEX:LCTX)’s traded shares were 0.5 million, with the beta value of the company hitting 1.28. At the
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.